Claim: maintenance glucocorticoids did not lower major relapse risk in ANCA-associated vasculitis

Claim
In a longitudinal cohort of ANCA-associated vasculitis, adding low-dose glucocorticoids during maintenance did not reduce major relapses, while higher glucocorticoid exposure tracked with more damage accumulation and more hospitalizations.
Evidence: RMD Open 2026, DOI 10.1136/rmdopen-2026-006935.
Limitations: observational cohort data, confounding by indication is likely, and this does not establish causality or a universal tapering rule.